Veys EM - Search Results

1

Exposure to nuclear antigens contributes to the induction of humoral autoimmunity during tumour necrosis factor alpha blockade.

Cantaert T, De Rycke L, Mavragani CP, Wijbrandts CA, Niewold TB, Niers T, Vandooren B, Veys EM, Richel D, Tak PP, Crow MK, Baeten D. Cantaert T, et al. Among authors: veys em. Ann Rheum Dis. 2009 Jun;68(6):1022-9. doi: 10.1136/ard.2008.093724. Epub 2008 Jul 14. Ann Rheum Dis. 2009. PMID: 18625621 Free PMC article.

2

Synovial inflammation does not change in the absence of effective treatment: implications for the use of synovial histopathology as biomarker in early phase clinical trials in rheumatoid arthritis.

Baeten D, Houbiers J, Kruithof E, Vandooren B, Van den Bosch F, Boots AM, Veys EM, Miltenburg AM, De Keyser F. Baeten D, et al. Among authors: veys em. Ann Rheum Dis. 2006 Aug;65(8):990-7. doi: 10.1136/ard.2005.047852. Epub 2006 Jan 13. Ann Rheum Dis. 2006. PMID: 16414969 Free PMC article.

3

Melanoma inhibitory activity, a biomarker related to chondrocyte anabolism, is reversibly suppressed by proinflammatory cytokines in rheumatoid arthritis.

Vandooren B, Cantaert T, van Lierop MJ, Bos E, De Rycke L, Veys EM, De Keyser F, Bresnihan B, Luyten FP, Verdonk PC, Tak PP, Boots AH, Baeten D. Vandooren B, et al. Among authors: veys em. Ann Rheum Dis. 2009 Jun;68(6):1044-50. doi: 10.1136/ard.2007.085837. Epub 2008 Jul 16. Ann Rheum Dis. 2009. PMID: 18633128

4

Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy.

De Rycke L, Vandooren B, Kruithof E, De Keyser F, Veys EM, Baeten D. De Rycke L, et al. Among authors: veys em. Arthritis Rheum. 2005 Jul;52(7):2146-58. doi: 10.1002/art.21155. Arthritis Rheum. 2005. PMID: 15986373 Free article. Clinical Trial.

5

In vitro spontaneous osteoclastogenesis of human peripheral blood mononuclear cells is not crucially dependent on T lymphocytes.

Vandooren B, Melis L, Veys EM, Tak PP, Baeten D. Vandooren B, et al. Among authors: veys em. Arthritis Rheum. 2009 Apr;60(4):1020-5. doi: 10.1002/art.24413. Arthritis Rheum. 2009. PMID: 19333923 Free article.

6

Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study.

Van den Bosch F, Kruithof E, Baeten D, De Keyser F, Mielants H, Veys EM. Van den Bosch F, et al. Among authors: veys em. Ann Rheum Dis. 2000 Jun;59(6):428-33. doi: 10.1136/ard.59.6.428. Ann Rheum Dis. 2000. PMID: 10834859 Free PMC article.

7

Repeated infusions of infliximab, a chimeric anti-TNFalpha monoclonal antibody, in patients with active spondyloarthropathy: one year follow up.

Kruithof E, Van den Bosch F, Baeten D, Herssens A, De Keyser F, Mielants H, Veys EM. Kruithof E, et al. Among authors: veys em. Ann Rheum Dis. 2002 Mar;61(3):207-12. doi: 10.1136/ard.61.3.207. Ann Rheum Dis. 2002. PMID: 11830424 Free PMC article.

8

Treatment of active spondyloarthropathy with infliximab, the chimeric monoclonal antibody to tumour necrosis factor alpha.

Van den Bosch F, Baeten D, Kruithof E, De Keyser F, Mielants H, Veys EM. Van den Bosch F, et al. Among authors: veys em. Ann Rheum Dis. 2001 Nov;60 Suppl 3(Suppl 3):iii33-6. doi: 10.1136/ard.60.90003.iii33. Ann Rheum Dis. 2001. PMID: 11890649 Free PMC article. Review. No abstract available.

9

Tumour necrosis factor alpha independent disease mechanisms in rheumatoid arthritis: a histopathological study on the effect of infliximab on rheumatoid nodules.

Baeten D, De Keyser F, Veys EM, Theate Y, Houssiau FA, Durez P. Baeten D, et al. Among authors: veys em. Ann Rheum Dis. 2004 May;63(5):489-93. doi: 10.1136/ard.2003.012302. Ann Rheum Dis. 2004. PMID: 15082477 Free PMC article.

10

Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis.

De Rycke L, Verhelst X, Kruithof E, Van den Bosch F, Hoffman IE, Veys EM, De Keyser F. De Rycke L, et al. Among authors: veys em. Ann Rheum Dis. 2005 Feb;64(2):299-302. doi: 10.1136/ard.2004.023523. Epub 2004 May 27. Ann Rheum Dis. 2005. PMID: 15166003 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

347 results

Search Page